Inhibition of Platelet Function by Recombinant Soluble Ecto-ADPase/Cd39.

Journal of Clinical Investigation - United States
doi 10.1172/jci1753
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

The Endothelial Cell Ecto-ADPase Responsible for Inhibition of Platelet Function Is CD39.

Journal of Clinical Investigation
Medicine
1997English

Glutathione Peroxidase Potentiates the Inhibition of Platelet Function by S-Nitrosothiols.

Journal of Clinical Investigation
Medicine
1995English

Efficient Inhibition of Collagen-Induced Platelet Activation and Adhesion by LAIR-2, a Soluble Ig-Like Receptor Family Member

PLoS ONE
Multidisciplinary
2010English

Recombinant Human Soluble CD4 Does Not Inhibit Immune Function in Cynomolgus Monkeys

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1991English

Inhibition of Platelet Prostaglandin Synthetase by Oral Aspirin.

Journal of Clinical Investigation
Medicine
1978English

Monitoring and Characterizing Soluble and Membrane-Bound Ectonucleotidases CD73 and CD39

PLoS ONE
Multidisciplinary
2019English

Inhibition of Hypersensitivity Reactions by Soluble Derivatives of Baicalein

The Japanese Journal of Pharmacology
1975English

In Vitro Effect of Plasmin on Human Platelet Function in Plasma. Inhibition of Aggregation Caused by Fibrinogenolysis

Circulation
Cardiovascular MedicinePhysiologyCardiology
1992English

N-Acetylcysteine Potentiates Inhibition of Platelet Aggregation by Nitroglycerin.

Journal of Clinical Investigation
Medicine
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy